文献速递骨质疏松与代谢性骨病

COVID-19 大流行期间 DXA 检查分诊的实用建议

A pragmatic proposal for triaging DXA testing during the COVID-19 global pandemic.
PubMed 文献 · Osteoporos Int · 2020-11-04

COVID-19 大流行导致 DXA 检查等待名单增加,可能延误骨质疏松治疗。作者提出一个结合用药情况(芳香化酶抑制剂、糖皮质激素)和临床风险分层补充标准 FRAX 评估的快速一站式算法,给出经验性治疗、DXA 成像或观察的建议。模型估计可减少约 50% 的 DXA 扫描数量,同时确保最高临床需求者及时治疗。

要点

  • 算法结合用药(芳香化酶抑制剂、糖皮质激素)与临床风险分层补充 FRAX。
  • 算法输出经验性治疗、DXA 成像或观察三类建议。
  • 模型估计可减少约 50% 的 DXA 扫描数量并减少治疗延误。

核心结论

  • 该实用算法可减少约 50% 的 DXA 扫描需求,并减少等待 DXA 者的治疗延误。

研究设计与样本

  • 本文为基于 COVID-19 大流行期间 DXA 等待名单增加背景的实用建议,未报告系统检索范围或样本量。

主要发现

  • 算法结合用药(芳香化酶抑制剂、糖皮质激素)和临床风险分层补充标准 FRAX 评估。
  • 算法产生经验性治疗、DXA 成像或观察的建议。
  • 模型估计应用后 DXA 扫描数量减少约 50%。

关键数值与推荐

  • 算法纳入用药因素包括芳香化酶抑制剂和糖皮质激素。
  • 算法以临床风险分层补充标准 FRAX 评估。
  • 算法输出建议为经验性治疗、DXA 成像或观察。

临床怎么用

  • 可帮助全科医生/家庭医生在缺乏单独临床判断经验时优先安排 DXA。
  • 该算法灵活,可依据当地指南、许可、处方要求和 DXA 等待时间调整。

局限性

  • 作者指出该建议存在一些局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The COVID-19 pandemic has resulted in huge disruption to healthcare provision, including to dual-energy X-ray absorptiometry (DXA) imaging. Increased waiting lists for DXA from the pandemic mean potential long and uncertain delays in treatment for osteoporosis. To address these increased waiting lists, we propose a rapid, simple, one-stop algorithm incorporating medication use (aromatase inhibitor, corticosteroid) and clinical risk stratification supplementing a standard FRAX assessment. Our pragmatic algorithm produces a recommendation to treat empirically, image with DXA, or observe. If applied, we model a significant reduction in DXA scan requirements with a corresponding reduction in treatment delays for those awaiting DXA. We estimate this will reduce DXA scan numbers by about 50%, whilst pragmatically ensuring those with the highest clinical need correctly receive treatment without delay. This algorithm will help many clinicians including general practitioners/family physicians prioritise DXA when they may not always have the expertise to make this judgement based on clinical information alone. Although we have used UK guidelines as an example, this approach is flexible enough for adaptation by other countries based on their local guidelines, licensing, prescribing requirements, and DXA waiting list times. There are some limitations to our proposal. However, it represents one way of managing the uncertainty of the current COVID-19 pandemic.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Sapkota HR, Nune A, Bateman J, et al. A pragmatic proposal for triaging DXA testing during the COVID-19 global pandemic. Osteoporos Int. 2020. PMID: 33146750. doi:10.1007/s00198-020-05722-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。